Josee Golay (Josée Golay)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Antibodies (Basel, Switzerland)

Blood

British journal of haematology

Azienda Ospedaliera Papa Giovanni XXIII

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliera Papa Giovanni XXIII Jan 01 2003

Italy

Director of research :: Haematology

Istituto Di Ricerche Farmacologiche Mario Negri Feb 03 1999 - Dec 31 2003

Italy

Head of the Research Unit :: Unità di Differenziazione Linfoide, Labotorio di Emato-immunologia Molecolare

Istituto Di Ricerche Farmacologiche Mario Negri - Feb 02 1999

Italy

Staff scientist :: Laboratory of Molecular Immuno-haematology

Istituto Di Ricerche Farmacologiche Mario Negri Jan 01 1989 - Jul 15 1998

Italy

Post-doc scientist :: Immunology Department

European Molecular Biology Laboratory Oct 01 1986 - Dec 31 1988

Germany

Post-doc scientist :: Differentiation program

Hammersmith Hospital

United Kingdom

Post-doc scientist :: Virology Department, Royal Postgraduate Medical School

Hammersmith Hospital

United Kingdom

Post-doc scientist :: Virology Department, Royal Postgraduate Medical School

Hammersmith Hospital

United Kingdom

Post-doc scientist :: Virology Department, Royal Postgraduate Medical School

Education History

University College London Oct 01 1982 - May 21 1986

United Kingdom

PHD

Publications

Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D'Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josee Golay, Martino Introna
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies (Basel, Switzerland) 13 (3) (2024)
Irene Cattaneo, Sylvie Choblet, Rut Valgardsdottir, Muriel Roth, Annamaria Massafra, Marten Beeg, Marco Gobbi, Martine Duonor-Cerutti, Josee Golay
Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1. Antibodies (Basel, Switzerland) 13 (1) (2024)
Irene Cattaneo, Sylvie Choblet, Rut Valgardsdottir, Muriel Roth, Annamaria Massafra, Marten Beeg, Marco Gobbi, Martine Duonor-Cerutti, Josee Golay
Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1. Antibodies (Basel, Switzerland) 13 (1) (2024)
Irene Cattaneo, Rut Valgardsdottir, Roberta Cavagna, Orietta Spinelli, Anna Bartoletti-Stella, Sabina Capellari, Monica Galli, Josee Golay
Genetic defects of gamma-secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report. British journal of haematology (2023)
Rut Valgardsdottir, Irene Cattaneo, Gavino Napolitano, Annibale Raglio, Orietta Spinelli, Silvia Salmoiraghi, Concetta Castilletti, Daniele Lapa, Maria Rosaria Capobianchi, Claudio Farina, Josee Golay
Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization. Antibodies (Basel, Switzerland) 10 (3) (2021)
Josee Golay, Alain E Andrea
Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies. Antibodies (Basel, Switzerland) 9 (2) (2020)
Josee Golay, Ronald P Taylor
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs. Antibodies (Basel, Switzerland) 9 (4) (2020)
Josee Golay, Rut Valgardsdottir, Gerta Musaraj, Damiano Giupponi, Orietta Spinelli, Martino Introna
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation. Blood 133 (13) (2019)
Rut Valgardsdottir, Irene Cattaneo, Christian Klein, Martino Introna, Marina Figliuzzi, Josee Golay
Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies. Blood 129 (19) (2017)

Josee Golay.css-eqlu8i{font-size:small;padding-left:4px;} (Josée Golay)

Publication Activity (10 Years)

Top Topics

Top Venues

Josee Golay (Josée Golay)